Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types

BACKGROUND: In 2008, a national human papillomavirus (HPV) immunisation programme began in Scotland for 12–13 year old females with a three-year catch-up campaign for those under the age of 18. Since 2008, three-dose uptake of bivalent vaccine in the routine cohort aged 12–13 has exceeded 90% annual...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavanagh, K, Pollock, K G J, Potts, A, Love, J, Cuschieri, K, Cubie, H, Robertson, C, Donaghy, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037824/
https://www.ncbi.nlm.nih.gov/pubmed/24736582
http://dx.doi.org/10.1038/bjc.2014.198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037824/
https://www.ncbi.nlm.nih.gov/pubmed/24736582
http://dx.doi.org/10.1038/bjc.2014.198

Ejemplares similares